Titan Medical Inc. Announces Voting Results from Its Annual and Special Meeting of Shareholders
31 Maio 2019 - 9:57AM
Business Wire
Titan Medical Inc. (“Titan” or the
“Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device
company focused on the design, development and commercialization of
a robotic surgical system for application in single-port minimally
invasive surgery, reported shareholder vote results from the
Company’s Annual and Special Meeting held on Wednesday, May 29,
2019.
All of management’s nominees for election were duly elected as
directors of the Company by the shareholders present or represented
by proxy at the meeting. A total of 22,305,951 of the 31,150,237
common shares outstanding were voted at the meeting. The results of
the vote were reported to the meeting by Computershare, which acted
as scrutineer at the meeting, as follows:
For
Number
%
Withheld
Number
%
John Barker 5,300,505 91.24 509,105 8.76 Charles Federico 5,736,442
98.74 73,168 1.26 David McNally 5,683,584 97.83 126,026 2.17
Stephen Randall 5,382,857 92.65 426,753 7.35 John Schellhorn
5,712,799 98.33 96,811 1.67 Domenic Serafino 5,718,221 98.43 91,389
1.57
The appointment of BDO Canada LLP as Auditors of the Company was
approved by shareholders (with 21,482,357 votes for and 823,594
votes withheld) in respect of the motion.
Shareholders passed the motion (with 3,637,601 votes for and
2,111,508 votes against) authorizing the SU Plan and DSU Plan.
Shareholders passed the motion (with 3,439,022 votes for and
2,310,087 votes against) authorizing amendments to the Stock Option
Plan.
Shareholders passed the motion (with 3,529,202 votes for and
2,252,734 votes against) authorizing the reduction of the exercise
prices of certain options granted to executive officers and
employees under the Option Plan.
Further particulars of the resolutions referenced above are set
forth in the management information circular of the Company dated
April 29, 2019.
The Company intends to post a video replay of the Annual and
Special Meeting on the investor tab of its website,
www.titanmedicalinc.com, before June 30, 2019.
About Titan Medical Inc.
Titan Medical Inc. is focused on computer-assisted robotic
surgical technologies for application in MIS. The Company is
developing the SPORT Surgical System, a single-port robotic
surgical system comprised of a surgeon-controlled patient cart that
includes a 3D high-definition vision system and multi-articulating
instruments for performing MIS procedures, and a surgeon
workstation that provides an advanced ergonomic interface to the
patient cart and a 3D endoscopic view inside the patient’s body.
Titan intends initially to pursue focused surgical indications for
the SPORT Surgical System, which may include one or more of
gynecologic, urologic, colorectal or general abdominal
procedures.
For more information, please visit the Company’s website at
www.titanmedicalinc.com.
Forward-Looking Statements
This news release contains “forward-looking statements” which
reflect the current expectations of management of the Company’s
future growth, results of operations, performance and business
prospects and opportunities. Wherever possible, words such as
“may”, “would”, “could”, “will”, “anticipate”, “believe”, “plan”,
“expect”, “intend”, “estimate”, “potential for” and similar
expressions have been used to identify these forward-looking
statements. These statements reflect management’s current beliefs
with respect to future events and are based on information
currently available to management. Forward-looking statements
involve significant risks, uncertainties and assumptions. Many
factors could cause the Company’s actual results, performance or
achievements to be materially different from any future results,
performance or achievements that may be expressed or implied by
such forward-looking statements, including, without limitation,
those listed in the “Risk Factors” section of the Company’s Annual
Information Form dated March 29, 2019 (which may be viewed at
www.sedar.com). Should one or more of these risks or uncertainties
materialize, or should assumptions underlying the forward-looking
statements prove incorrect, actual results, performance, or
achievements may vary materially from those expressed or implied by
the forward-looking statements contained in this news release.
These factors should be considered carefully, and prospective
investors should not place undue reliance on the forward-looking
statements. Although the forward-looking statements contained in
the news release are based upon what management currently believes
to be reasonable assumptions, the Company cannot assure prospective
investors that actual results, performance or achievements will be
consistent with these forward-looking statements.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190531005332/en/
LHA Investor RelationsKim Sutton Golodetz(212)
838-3777kgolodetz@lhai.comorBruce Voss(310)
691-7100bvoss@lhai.com
Titan Medical (NASDAQ:TMDI)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Titan Medical (NASDAQ:TMDI)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024